A direct supply of Bharat Biotech’s Covaxin has been commenced to 14 states with effect from May 1, said Suchitra Ella, company’s Joint Managing Director.
The Hyderabad-based firm has started supplying its Covid-19 treatment vaccine to the states based on the allocations received by the central government.
“Bharat Biotech confirms direct supplies of COVAXIN to the following state govt’s since 1/5/21, based on the allocations received by GoI. Requests have been received from other states, & will be processed for distribution based on availability of stocks 24×7,” Ella tweeted.
The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh, Delhi, Maharashtra and West Bengal.
On April 29, Bharat Biotech announced a cut in the price of ‘Covaxin’ for states to ₹400 per dose from the earlier ₹600 per dose.
This followed widespread criticism of its pricing policy as it sold Covaxin to the central government at ₹150 per dose.
India has announced expansion of its Covid-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.
Antibiotic use has surged globally, leading to a rise in antibiotic resistance, especially concerning in…
Choking is a leading cause of injury and death in young children, particularly those under…
Hard Water (Khara Pani) Leading To Hair Fall Hard water is rich in minerals and…
Discover how the rise in high blood pressure during pregnancy is impacting maternal and fetal…
"Discover the transformative power of six delicious homemade drinks that can help you naturally melt…
"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…